936663055	936663055	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
03543874	03543874	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4252810	4252810	CD	B-NP	O
|	|	CC	I-NP	O
9/25/2006	9/25/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/8/2006	1/8/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/12/2006	10/12/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
KRAUS	KRAUS	NN	B-NP	O
,	,	,	O	O
RALEIGH	RALEIGH	NN	B-NP	B-protein
LOUIS	LOUIS	NNP	I-NP	I-protein
MD	MD	NNP	I-NP	I-protein
HISTORY	HISTORY	NNP	I-NP	I-protein
OF	OF	IN	B-PP	I-protein
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
67-year-old	67-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
67-year-old	67-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
first	first	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
back	back	RP	B-PRT	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
stent	stent	JJ	I-NP	O
placed	placed	NN	I-NP	O
at	at	IN	B-PP	O
THC	THC	NN	B-NP	B-protein
for	for	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
feeling	feel	VBG	I-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
10/14	10/14	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
burning	burning	NN	I-NP	O
and	and	CC	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Trowestpot	Trowestpot	NNP	B-NP	O
Allch	Allch	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
a	a	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
details	detail	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
IIAH	IIAH	NN	B-NP	B-protein
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
Deran	Deran	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
angiography	angiography	NN	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
with	with	IN	B-PP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Cypher	Cypher	NNP	I-NP	O
stent	stent	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
evening	evening	NN	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
severe	severe	JJ	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
activated	activate	VBD	B-VP	O
her	her	PRP$	B-NP	O
local	local	JJ	I-NP	O
EMS	EMS	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
suffered	suffer	VBD	B-VP	O
a	a	DT	B-NP	O
Vfib	Vfib	NN	I-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
requiring	require	VBG	B-VP	O
CPR	CPR	NN	B-NP	B-protein
and	and	CC	O	O
9	9	CD	B-NP	O
defibrillations	defibrillation	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
Geft.o	Geft.o	NNP	B-NP	O
Ton	Ton	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
acutely	acutely	RB	I-VP	O
intervened	intervene	VBN	I-VP	O
upon	upon	IN	B-PP	O
with	with	IN	B-PP	O
PTCA	PTCA	NN	B-NP	B-protein
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
thrombosed	thrombose	VBN	I-NP	O
LAD	LAD	NN	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
R.	R.	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Of	Of	IN	B-ADVP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
intraaortic	intraaortic	JJ	I-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
for	for	IN	B-PP	O
support	support	NN	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
angiography	angiography	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
revealing	reveal	VBG	B-VP	O
suboptimal	suboptimal	JJ	B-NP	O
deployment	deployment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
outsized	outsize	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
diameter	diameter	NN	I-NP	O
of	of	IN	B-PP	O
3.5	3.5	CD	B-NP	O
mm	mm	NN	I-NP	O
and	and	CC	O	O
additional	additional	JJ	B-NP	O
stenting	stenting	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
distal	distal	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
original	original	JJ	I-NP	O
stent	stent	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
anterograde	anterograde	NN	I-NP	O
flow	flow	NN	I-NP	O
noted	note	VBD	B-VP	O
postprocedure	postprocedure	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
intraaortic	intraaortic	JJ	I-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
distributive	distributive	JJ	B-NP	O
and	and	CC	I-NP	O
cardiogenic	cardiogenic	JJ	I-NP	O
shock	shock	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	I-NP	O
HSV	HSV	NN	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
improved	improve	VBD	B-VP	O
after	after	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
5/14/06	5/14/06	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
to	to	TO	B-PP	O
Tacan	Tacan	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
And	And	CC	B-PP	O
on	on	IN	B-PP	O
6/16/06	6/16/06	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
and	and	CC	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
1/27/06	1/27/06	CD	B-NP	O
.	.	.	O	O

Echocardiography	Echocardiography	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	I-NP	O
RVSP	RVSP	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
represented	represent	VBN	B-VP	O
to	to	TO	B-PP	O
Harl	Harl	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
9/23/06	9/23/06	CD	B-NP	O
reporting	report	VBG	B-VP	O
progressive	progressive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
repeat	repeat	NN	B-NP	O
angiography	angiography	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
RA	RA	NN	B-NP	B-protein
14	14	CD	I-NP	I-protein
,	,	,	O	O
RV	RV	NN	B-NP	B-protein
55/13	55/13	CD	I-NP	I-protein
,	,	,	O	O
PA	PA	NN	B-NP	B-DNA
61/25/42	61/25/42	CD	I-NP	I-DNA
,	,	,	O	O
PCWP	PCWP	NN	B-NP	B-protein
35	35	CD	I-NP	I-protein
with	with	IN	B-PP	O
V	V	NN	B-NP	B-protein
246	246	CD	I-NP	I-protein
,	,	,	O	O
LHC	LHC	NN	B-NP	B-protein
with	with	IN	B-PP	O
AO	AO	NN	B-NP	B-protein
86/57	86/57	CD	I-NP	I-protein
.	.	.	O	O

Angiography	Angiography	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
and	and	CC	I-NP	O
LMCA	LMCA	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
patent	patent	NN	B-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
mid	mid	NN	I-NP	O
,	,	,	O	O
D1	D1	NN	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
ostial	ostial	JJ	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
prox	prox	NN	I-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
gram	gram	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
MR.	MR.	NN	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Palm	Palm	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Systems	System	NNPS	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
advanced	advanced	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-VP	O
above	above	VB	I-VP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Diovan	Diovan	NNP	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
88	88	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zetia	Zetia	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
Aldactone	Aldactone	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
500/50	500/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	O
70/30	70/30	CD	I-NP	O
,	,	,	I-NP	O
30	30	CD	I-NP	O
units	unit	NNS	I-NP	O
subq	subq	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
erythromycin	erythromycin	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
and	and	CC	O	O
works	work	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
clothing	clothing	NN	I-NP	O
company	company	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
smokes	smoke	VBZ	B-VP	O
1-2	1-2	CD	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
x46	x46	CD	B-NP	O
years	year	NNS	I-NP	O
until	until	IN	B-PP	O
nine	nine	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
illicits	illicit	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
sibling	sibling	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
premature	premature	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Mother	Mother	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
alcoholism	alcoholism	NN	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
fever	fever	RB	B-ADVP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
hemoptysis	hemoptysis	NN	B-NP	O
,	,	,	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
hematochezia	hematochezia	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
melena	melena	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
or	or	CC	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
exposures	exposure	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
travel	travel	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
presyncope	presyncope	NN	I-NP	O
or	or	CC	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
0.7	0.7	CD	B-NP	O
to	to	TO	B-PP	O
0.8	0.8	CD	B-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
34	34	CD	B-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
37	37	CD	I-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
68	68	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
33	33	CD	I-NP	O
and	and	CC	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
384	384	CD	I-NP	O
down	down	IN	B-ADVP	O
from	from	IN	B-PP	O
616	616	CD	B-NP	O
on	on	IN	B-PP	O
last	last	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
intervals	interval	NNS	I-NP	O
with	with	IN	B-PP	O
old	old	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
septal	septal	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
afebrile	afebrile	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
98/60	98/60	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
18-20	18-20	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
resting	rest	VBG	B-VP	O
comfortably	comfortably	RB	B-ADVP	O
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotids	carotid	NNS	I-NP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
thyromegaly	thyromegaly	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
with	with	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
expiratory	expiratory	JJ	I-NP	O
phase	phase	NN	I-NP	O
and	and	CC	O	O
intermittent	intermittent	JJ	B-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

Notable	Notable	JJ	B-NP	O
S3	S3	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
MR	MR	NN	I-NP	B-protein
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
distended	distended	JJ	I-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
shins	shin	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Pretibial	Pretibial	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
other	other	JJ	I-NP	O
rashes	rash	NNS	I-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
groin	groin	NN	I-NP	O
minimally	minimally	RB	B-ADVP	O
tender	tender	NN	B-NP	O
without	without	IN	B-PP	O
bruit	bruit	NN	B-NP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
site	site	NN	I-NP	O
clean	clean	JJ	B-NP	O
,	,	,	I-NP	O
dry	dry	JJ	I-NP	O
,	,	,	I-NP	O
intact	intact	JJ	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	B-protein
exam	exam	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
67-year-old	67-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
including	include	VBG	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
LAD	LAD	NN	I-NP	O
stent	stent	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
subacute	subacute	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
with	with	IN	B-PP	O
marked	marked	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
reportedly	reportedly	RB	I-NP	O
revascularized	revascularize	VBN	I-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
territory	territory	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
on	on	IN	B-PP	O
repeat	repeat	NN	B-NP	O
echo	echo	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
with	with	IN	B-PP	O
biventricular	biventricular	JJ	B-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
medically	medically	RB	B-NP	O
optimized	optimize	VBN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RBR	I-VP	O
clarify	clarify	VB	I-VP	O
component	component	NN	B-NP	O
of	of	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
TTE	TTE	NN	I-NP	O
and	and	CC	I-NP	O
right	right	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
heart	heart	NN	B-NP	O
catheterization	catheterization	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
and	and	CC	I-VP	O
optimize	optimize	VB	I-VP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	I-NP	O
Plavix	Plavix	NN	I-NP	O
,	,	,	I-NP	O
ARB	ARB	NN	I-NP	B-protein
,	,	,	I-NP	O
statin	statin	NN	I-NP	O
and	and	CC	I-NP	O
Zetia	Zetia	NN	I-NP	O
.	.	.	O	O

Beta-blocker	Beta-blocker	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
given	give	VBN	B-PP	O
decompensated	decompensated	JJ	B-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

Adenosine	Adenosine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
was	be	VBD	B-VP	O
completed	complete	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
recovery	recovery	NN	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
and	and	CC	O	O
aVF	aVF	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

EF	EF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
severely	severely	RB	I-VP	O
depressed	depress	VBN	I-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
on	on	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
reproducible	reproducible	JJ	B-ADJP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
benefit	benefit	NN	B-NP	O
of	of	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
surgery	surgery	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
benefit	benefit	NN	B-NP	O
given	give	VBN	B-VP	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
on	on	IN	B-PP	O
repeat	repeat	NN	B-NP	O
echo	echo	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
a	a	DT	B-NP	O
contrast	contrast	NN	I-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
clot	clot	NN	B-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
severe	severe	JJ	I-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
malfunction	malfunction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
anticoagulation	anticoagulation	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
clot	clot	NN	B-NP	O
on	on	IN	B-PP	O
echo	echo	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
echo	echo	NN	B-NP	O
,	,	,	O	O
reevaluated	reevaluate	VBN	B-VP	O
for	for	IN	B-PP	O
dyssynchrony	dyssynchrony	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
until	until	IN	B-PP	O
near	near	JJ	B-NP	O
euvolemic	euvolemic	JJ	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	FW	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Aldactone	Aldactone	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
EP	EP	NN	I-NP	O
service	service	NN	I-NP	O
evaluated	evaluate	VBN	B-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
AICD	AICD	NN	B-NP	O
versus	versus	CC	O	O
biventricular	biventricular	JJ	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
yet	yet	RB	B-ADJP	O
outside	outside	JJ	I-ADJP	O
of	of	IN	B-PP	O
three-month	three-month	JJ	B-NP	O
window	window	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noninducible	noninducible	JJ	B-ADJP	O
on	on	IN	B-PP	O
EP	EP	NN	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
close	close	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
with	with	IN	B-PP	O
repeat	repeat	NN	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
further	further	JJ	I-NP	O
EP	EP	NN	I-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
readdress	readdress	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
meantime	meantime	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Inhalers	Inhaler	NNS	B-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

PFTs	PFT	NNS	B-NP	O
and	and	CC	O	O
VO2	VO2	NN	B-NP	O
study	study	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
mild	mild	JJ	B-NP	O
dye	dye	NN	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
and	and	CC	O	O
overaggressive	overaggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
stabilized	stabilize	VBD	B-VP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
electrolytes	electrolyte	NNS	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	B-protein
heart	heart	NN	I-NP	I-protein
failure	failure	NN	I-NP	I-protein
versus	versus	IN	B-PP	I-protein
statin	statin	NN	B-NP	I-protein
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
trended	trend	VBD	B-VP	O
down	down	RP	B-PRT	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
and	and	CC	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
bridge	bridge	NN	I-NP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
bridge	bridge	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
with	with	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Levoxyl	Levoxyl	NNP	B-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
bacteriuria	bacteriuria	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
possible	possible	JJ	B-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
developed	develop	VBD	B-VP	O
itchiness	itchiness	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Bactrim	Bactrim	NNP	I-NP	O
.	.	.	O	O

Provided	Provide	VBN	B-NP	O
supportive	supportive	JJ	I-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
avoid	avoid	VB	I-VP	O
Bactrim	Bactrim	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
intolerance	intolerance	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
serious	serious	JJ	I-NP	O
reactions	reaction	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Psychiatric	Psychiatric	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
sodium	sodium	NN	B-NP	O
and	and	CC	I-NP	O
volume	volume	NN	I-NP	O
restriction	restriction	NN	I-NP	O
,	,	,	O	O
K	K	NN	B-NP	O
mag	mag	NN	I-NP	O
scales	scale	NNS	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

Dermatologic	Dermatologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
HSV	HSV	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
acyclovir	acyclovir	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
further	further	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
pretibial	pretibial	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
derm	derm	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
,	,	,	O	O
which	which	WDT	B-NP	O
they	they	PRP	B-NP	O
felt	feel	VBD	B-VP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
steroid	steroid	NN	B-NP	O
cream	cream	NN	I-NP	O
and	and	CC	I-NP	O
compression	compression	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
prophylaxed	prophylaxe	VBN	I-VP	O
with	with	IN	B-PP	O
Protonix	Protonix	NN	B-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
,	,	,	O	O
weigh	weigh	VB	B-VP	O
herself	herself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
with	with	IN	B-PP	O
careful	careful	JJ	B-NP	O
notice	notice	NN	I-NP	O
to	to	TO	B-PP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
reporting	report	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
returne	returne	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
a	a	DT	B-NP	O
fluid	fluid	NN	I-NP	O
restricted	restrict	VBD	B-VP	O
,	,	,	O	O
low-fat	low-fat	JJ	B-NP	O
,	,	,	I-NP	O
low-cholesterol	low-cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
restricted	restricted	JJ	I-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Kuhnke	Kuhnke	NNP	I-NP	O
at	at	IN	B-PP	O
786-179-5001	786-179-5001	CD	B-NP	O
on	on	IN	B-PP	O
1/4/06	1/4/06	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Yatsko	Yatsko	NNP	I-NP	O
at	at	IN	B-PP	O
051-469-9935	051-469-9935	CD	B-NP	O
on	on	IN	B-PP	O
3/12/06	3/12/06	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
1/1/06	1/1/06	CD	B-NP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
INRs	INR	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INRs	INR	NNS	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
puffs	puff	NNS	I-NP	I-protein
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
fluoxetine	fluoxetine	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
35	35	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subq	subq	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
med	me	VBN	B-VP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
88	88	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
nortriptyline	nortriptyline	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Ambien	Ambien	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
insomnia	insomnia	NNP	I-NP	O
,	,	,	I-NP	O
Diovan	Diovan	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
500/50	500/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
esomeprazole	esomeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
Zetia	Zetia	NNP	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-8706120	8-8706120	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
YOCHIM	YOCHIM	NNP	B-NP	O
,	,	,	O	O
BRENDON	BRENDON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MCRAVIN	MCRAVIN	NNP	B-NP	O
,	,	,	O	O
PABLO	PABLO	NNP	B-NP	O
JOAQUIN	JOAQUIN	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7491275	7491275	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/1/06	1/1/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/1/06	1/1/06	CD	B-NP	O

